Skip to NavigationSkip to content

MSD to launch Keytruda at half US list price in China

Published on 20/09/18 at 10:09am

US pharma giant MSD will offer cutting edge cancer treatment Keytruda to Chinese patients at half the price at what it is sold for in the United States, according to the Beijing-based news organisation Caixin Global.

Keytruda, which was approved in China in July of this year, will cost 17,918 yuan (£1,981) for a 100mg/ 4ml dose when it is introduced to the world’s second largest pharmaceutical market later this year.

The reduced price thus marks the lowest price at which Keytruda is sold around the world, at 50% of the US price and 30% lower than that of neighbouring Hong Kong.

The move comes after BristolMyersSquibb cut the price of cancer treatment Opdivo after it was authorised by the China Food and Drug Administration in June for patients with locally advanced or metastatic non-small-cell lung cancer. The therapy, which became the first PD-1 inhibitor approved in China, comes with a list price of 9260 yuan (£1023).

MSD have also announced that they have developed a patient financial assistance program for Keytruda, which will increase access for the humanised antibody which is used in cancer immunotherapy.

Louis Goss

Comments

Thanks for this informative article here on our website you will play free online yahtzee games with all unlocked level and play as multiplayer by connecting your friends.

A firm file and document is brought for the happiness for the citizens. The charge of the firm and cheapwritingservice.com reviews is approved for the counting of the terms for the candidates. The injunction is filled for the approach of the terms for the field of the approval of the orders for the humans.

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches